Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

The respiratory care devices market is projected to grow from $24.16 billion in 2024 to $49.19 billion by 2033, at a CAGR of 8.22%. The rise is fueled by increasing cases of respiratory diseases such ...

KØBENHAVN, DK / ACCESS Newswire / November 24, 2025 / FluoGuide A/S (STO:FLUO)("FluoGuide" or the "Company" held an extraordinary general meeting on 24 November 2025.To the shareholders of FluoGuide A ...

RINJ claims full and unfettered freedom in the exercise of its functions.

COPD, which includes chronic bronchitis and emphysema, is progressive, meaning it gets worse over time without treatment.

An Oban granny has told how she is ’crippled’ by an agonising oesophagus disorder - that can only be remedied by eating Love ...

COPD affects 1.7 million people in the UK, making it harder to breathe. Here are the key signs to look out for.

Coughing is one of the most common and noticeable symptoms of the condition, but it’s specifically a cough that lasts a long ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic ...